A POOLED SAFETY ANALYSIS FROM THE USTEKINUMAB CROHN?S DISEASE AND PSORIATIC DISEASES PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS

Subrata Ghosh  1     Bruce E. Sands  2     Willem de Villiers  3     Elyssa Ott  4     Christopher Gasink  5     Yinghua Lang     Philippe Szapary     Douglas Jacobstein     Brian G. Feagan    
1 Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Canada
2 Icahn School of Medicine at Mt Sinai, New York, United States of America
3 University of Stellenbosch, Stellenbosch, South Africa
4 Janssen Research & Development, LLC, Spring House, United States of America
5 Janssen Research & Developme

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing